Pipeline

Psivant Therapeutics has a differentiated pipeline of targets with high biological and disease validation that have historically provided challenges for the design of therapeutics.

Best-in-Class Small Molecules

Target
Area of Focus
Exploratory
Discovery
Pre-Clinical
Animated Model of IRAK4 and IRAK1

IRAK1/IRAK4

Dual IRAK1/IRAK4 Inhibitor

Focus: Inflammation

Status: Discovery


Animated Model of WEE1 and PKMYT1

WEE1/PKMYT1

Dual WEE1/PKMYT1 Inhibitor

Focus: Oncology

Status: Discovery


Animated Model of WEE1

WEE1

Selective Inhibitor

Focus: Oncology

Status: Discovery


Undisclosed

Allosteric Inhibitor

Focus: Inflammation and Immunology

Status: Exploratory


Undisclosed

Allosteric Inhibitor

Focus: Inflammation and Immunology

Status: Exploratory


Target Animations by Istvan Kolossvary